Global Faculty
Surgeons and oncologists shaping cancer care worldwide.
Our faculty bring together decades of clinical leadership across four continents — uniting to teach, mentor, and advance urologic oncology.
Dr. Murugesan Manoharan
Professor and Chair — Department of Urology, Chief of Urologic Oncology, Director of Robotic Urologic Surgery
Miami Cancer Institute
A renowned leader in the treatment of prostate, kidney, bladder and other urologic malignancies, and Director of Robotic Urologic Surgery. An expert in minimally invasive surgery — including nerve-sparing robotic prostatectomy, robotic bladder removal and neobladder reconstruction — his research interests span stem-cell applications, biomarkers and cancer outcomes.
Dr. Jorge Caso
Associate Professor of Urology, Chief of Urologic Oncology
Tulane University School of Medicine
Specialises in the medical and surgical treatment of kidney, prostate, bladder, and testicular cancers, with extensive experience in laparoscopic single-site and robotic platforms for nephrectomy and partial nephrectomy. His interests include outcomes-based research and novel surgical techniques.
Dr. Manuel Ozambela Jr
Associate Professor of Urology, Herbert Wertheim College of Medicine, Associate Residency Program Director
Miami Cancer Institute
Strives to identify new diagnostic and treatment options for genitourinary cancers, improve patient recovery after surgery, and enhance quality of life. Through excellent communication and shared decision-making, he works with patients to create individual treatment plans.
Dr. Ahmed Eldefrawy
Associate Professor of Urology, Herbert Wertheim College of Medicine
Miami Cancer Institute
Treats cancers of the male reproductive organs and the urinary tract, including bladder, kidney, testicular, adrenal and prostate cancers. Mindful of the emotional impact of a cancer diagnosis, his goal is to be available and supportive to his patients while keeping them informed at all times.
Dr. Jan Rudzinski
Associate Professor of Urology, Herbert Wertheim College of Medicine
Miami Cancer Institute
Committed to ongoing surgical education, training and quality improvement to enhance patient care and oncologic outcomes. He prioritises the needs, preferences and values of patients, and is actively involved in clinical and translational research.
Dr. Rohan Garje
Chief of Genitourinary Medical Oncology
Miami Cancer Institute
Specialises in prostate, kidney, bladder, testicular and penile cancer, with significant expertise in designing novel investigator-initiated clinical trials. He focuses on precision oncology — targeted therapy, immunotherapy, radioligand therapy and chemotherapy — and individualised care for every patient.
Dr. Hariharan Palayapalayam Ganapathi
Chief of Urology and Medical Director of Urological Oncology and Robotic Surgery
Mercyhealth, Janesville, Wisconsin
His clinical expertise includes robotic urologic oncology, benign prostatic hyperplasia and complex stone disease. He is actively involved in surgical education, simulation-based learning, and international hands-on workshops in minimally invasive and robotic urology.
Dr. Gokul Kanda Swamy
Associate Professor of Urology, Herbert Wertheim College of Medicine, Associate Residency Program Director
Miami Cancer Institute
Specialises in prostate and bladder cancers and performs cystectomies and both open and robotic prostatectomies. He has provided pelvic-oncology services across Swansea Bay and Hywel Dda University Health Boards in the UK.
Dr. Sivaneswaran L
Consultant Urologist & Head of Urology Unit
Hospital Raja Permaisuri Bainun, Ipoh
A highly credentialed urologist and general surgeon. He holds an MBBS from Manipal, MRCS (Ireland), a Master of Surgery from the University of Malaya, FRCS in Urology from Glasgow, and completed a Fellowship in Urology in Melbourne.
Dr. Ragavan N
Adjunct Professor UroOncology, MGR University · Senior Consultant Urological Surgeon & Uro-Oncologist
Apollo Hospitals, Chennai
Trained and worked as a Consultant Urologist and Uro-Oncologist in the UK, followed by a fellowship under Prof. Stolzenburg (Germany). With 30 years of uro-oncology expertise across open, laparoscopy and robotic surgery, he is a keen academician who mentors urology trainees.
Dr. Raghunath SK
Director & Head of Urologic Oncology & Robotic Surgery
HCG Cancer Hospital, Bengaluru
A leading uro-oncologist and robotic surgeon with experience spanning over 5,000 uro-oncological procedures — including more than 1,950 robotic surgeries. A fellowship-trained specialist with international exposure in Taiwan and the USA, with significant contributions to prostate-cancer research.
Dr. Tushar Aditya Narain
Director & Lead Surgeon of Urologic Oncology & Robotic Surgery
Max Smart Super Specialty Hospital, Saket
Fellowship-trained in robotic prostate and bladder cancer surgery at University College London Hospital NHS (UCLH). His clinical focus spans cancers of the prostate, kidneys, bladder, ureters, testes and penis, with significant contributions to urological-oncology research.
Prof. Sanjai Addla
Senior Consultant Uro-Oncologist
Apollo Cancer Centre, Apollo Hospital, Hyderabad
Provides comprehensive, state-of-the-art evaluation across the spectrum of urologic cancers, with expertise in robotic partial nephrectomy and radical prostatectomy. He chairs the USI Uro-oncology subsection and the National Cancer Grid Uro-Oncology guidelines panel for India.
Dr. Ginil Kumar Pooleri
Professor of Urology
Amrita Institute of Medical Sciences, Kochi
Leads one of the fastest-growing robotic and uro-oncology programs in India and runs a University fellowship program in Uro-Oncology & Robotic surgery. He helped found organisations including the Society of Genitourinary Oncologists (SOGO) and the Academy of Urooncology.
Dr. Pushan Prabhakar
Research Associate
Miami Cancer Institute
A researcher specialising in urologic oncology, robotic-surgery outcomes, and clinical cancer research across bladder, prostate and kidney cancers, with work presented at major international conferences. Committed to advancing evidence-based medicine through research and emerging technologies.